An injectable HIV treatment regimen that replaces daily HIV pills for HIV-1 infection.
Cabenuva: An injectable HIV treatment regimen that replaces daily HIV pills for HIV-1… · Jul 28–Aug 17, 2026
NewCabenuva is an injectable HIV treatment regimen that offers the convenience of not requiring daily pills for HIV-1 infection.
13-week activity
Public campaign reads by observed week
Renewal signals
No recurring promo code was observed.
Shows
Where the campaign appearedRepresentative reads
Examples across the campaignExample transcript
The read that best represents this campaign's recurring script
This message is brought to you by Injectable Cabanova, Cabotegravir, Rilpivirine. Here's a question for you. Are you ready for a complete HIV treatment that doesn't demand daily attention? Then you're ready to talk to your doctor about Cabanova. Cabanova helps keep your HIV in check with no more daily HIV pills. Results may vary. Attend all appointments. Cabinuva is a complete prescription regimen used to treat HIV-1 infection in people 12 years and older who weigh at least 77 pounds or 35 kilograms to replace their current HIV-1 medicines when their health care provider determines they meet certain requirements. Don't take cabinuva if allergic or taking medicines that may interact. Serious side effects, allergic reactions or rash, post-injection reactions, liver problems, and depression. If these occur, get medical help right away. Tell your doctor about your medicines or supplements, medical conditions, liver or kidney problems, mental health, pregnancy, and breastfeeding. The most common side effect is injection site reaction. Talk to your doctor and learn more by calling 1-800-946-4323 or visiting cabenuva.com. That's C-A-B-E-N-U-V-A dot com.
More campaigns from Cabenuva
Other published campaigns from this sponsor
The campaign promotes Injectable Cabanuva by encouraging listeners to consider if an injectable treatment is right for them and to evaluate Cabanuva as a different treatment option.
The campaign encourages listeners who may be considering an injectable treatment to look more closely at Cabenuva and decide if it is the right time for a different treatment.
The campaign promotes Injectable Cabenuva by encouraging listeners to check insurance coverage and utilize an access coordinator for guidance on discussing injectable treatment with their doctor.
These signals describe observed podcast advertising activity. Per-read dollar figures are directional current placement proxies—not historical campaign spend, reach, conversions, or return on investment.